In both inoculated and BMET-derived cells, tumoral PTHrP secretion was further increased (P ≤ 0.05) in response to E2 treatment, resulting in 2-fold higher levels of E2-induced PTHrP secretion from BMET-derived (vs. inoculated) ER+ tumor cells. This evidence concerns the gene PTHLH and neoplasm.